Page last updated: 2024-10-20

pqq cofactor and Atherosclerotic Parkinsonism

pqq cofactor has been researched along with Atherosclerotic Parkinsonism in 2 studies

PQQ Cofactor: A pyrrolo-quinoline having two adjacent keto-groups at the 4 and 5 positions and three acidic carboxyl groups. It is a coenzyme of some DEHYDROGENASES.
pyrroloquinoline quinone : A pyrroloquinoline having oxo groups at the 4- and 5-positions and carboxy groups at the 2-, 7- and 9-positions.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Cheng, Q1
Chen, J1
Guo, H1
Lu, JL1
Zhou, J1
Guo, XY1
Shi, Y1
Zhang, Y2
Yu, S2
Zhang, Q2
Ding, F2
Qin, J1
Wu, M1
Gao, X1
Zhang, J1
Dong, X1
Ji, J1
Zhou, L1

Other Studies

2 other studies available for pqq cofactor and Atherosclerotic Parkinsonism

ArticleYear
Pyrroloquinoline quinone promotes mitochondrial biogenesis in rotenone-induced Parkinson's disease model via AMPK activation.
    Acta pharmacologica Sinica, 2021, Volume: 42, Issue:5

    Topics: AMP-Activated Protein Kinases; Animals; Behavior, Animal; Cell Line, Tumor; Humans; Locomotion; Male

2021
Pyrroloquinoline quinone-conferred neuroprotection in rotenone models of Parkinson's disease.
    Toxicology letters, 2015, Nov-04, Volume: 238, Issue:3

    Topics: Animals; Antioxidants; Cell Line; Cell Survival; Gene Expression Regulation; Glutathione; Humans; Ma

2015